The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

On March 23, 2025, 23andMe Holding Co. (Nasdaq: ME), a prominent genetics and biotechnology firm, announced it has ...

Sanofi, one of the world’s largest pharmaceutical companies, has acquired the Serbian biopharmaceutical company Dren Bio for ...

Alexandria Real Estate Equities has unveiled plans for a mega-project in the San Francisco Peninsula that will transform an ...

Me's drugs and patents — including two possible deals — could be key to its exit out of Chapter 11 bankruptcy protection.

Neuron23 has announced the publication of a manuscript in PNAS exploring the role of TYK2 inhibition in multiple sclerosis (MS) and neuroinflammation.

Alumis shares rose after the company signed a licensing agreement, worth $40 million in the short-term, with Tokyo-based Kaken Pharmaceutical. The stock climbed 17.9% to $4.45 on Tuesday, recovering ...

Me on Sunday filed for bankruptcy in the U.S. after struggling with the fallout of a data breach and weak demand for its ...

Women In Bio (WIB) celebrates an expansion of its Executive Women In Bio program that supports access to networking, ...

According to the company’s U.S. privacy statement, if 23andMe is involved in a “bankruptcy, merger, acquisition, ...

Many 23andMe customers signed up to the genetic testing service in hopes of learning fun or interesting information about ...

Jotform, a leading online form builder and automation platform, today announced the launch of Jotform Boards. This powerful new product auto-generates tasks from form responses, AI Agent conversations ...